Effectiveness and safety of caplacizumab in acquired thrombotic thrombocytopenic purpura: health technology assessment and classification according to the methodology established in Colombia
Published in
International Journal of Technology Assessment in Health Care, July 2023
Jahir A. Soto-Mora, Lina M. Gómez-Espitia, Pieralessandro Lasalvia, Camilo A. Castellanos Moreno, Carol A. Casallas Vanegas, Sergio A. Londoño Gutiérrez
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2023.
All research outputs
#3,284,250
of 26,398,142 outputs
Outputs from International Journal of Technology Assessment in Health Care
#159
of 1,808 outputs
Outputs of similar age
#55,832
of 371,824 outputs
Outputs of similar age from International Journal of Technology Assessment in Health Care
#1
of 24 outputs
Altmetric has tracked 26,398,142 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,808 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,824 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.
